Haptoglobin

N/A

Report date: 2024/12/04 14:51:18

NME

Base Information

Drug NameHaptoglobin

Drug Alias NameCSL-888

ClassificationSmall molecules

Mechanisms of ActionHaptoglobin replacements

TargetsHaptoglobin

Therapy Area/IndicationsSubarachnoid Hemorrhage

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCsl Behring

China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring

Inactive CompaniesN/A

Active IndicationsSubarachnoid Hemorrhage

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A